‘India Represents One Of The Top Growing Markets For Terumo Bct In Asia Pacific'

Since early 1980s, Terumo BCT, a US-based blood bank technology major has a presence in India and operates an R&D facility at Trivandrum. Recently, David Perez, its President & CEO was in India for business expansion. In an exclusive interview with Lakshmipriya Nair, he outlines his company’s vision for this country and the roadmap to achieve them.

- Lakshmipriya Nair

Brief us on the highlights of your visit to India? 

India has been important to Terumo BCT for many years. Terumo Penpol in Trivandrum is our Indian subsidiary, which manufactures close to 30 million blood bags each year making it among the largest blood bag manufacturer in the globe. I was here to meet our team and better understand our plans for the future, and I cannot express how excited I became when I heard, saw and learned more about the work that is being done by the team in Trivandrum.

Besides meeting with my fellow associates and seeing the progress of our new R&D building in Trivandrum, I was here to meet customers, given my trip was very brief, I could meet just a few.

My trip also coincided with the announcement of our collaboration with the research and development experts at Capgemini India. We also work with TechMahindra. These are major firms with deep expertise in disciplines including the power of connected devices, internet of things and artificial intelligence. Technology is helping us fulfil our mission of unlocking the potential of blood. It makes perfect sense to collaborate with firms like these, and leverage their expertise learned across other industries such as telecom, life sciences and high tech.